Piet Borst, Jose Baselga, Matt van de Rijn, David Kerr, C. Kent Osborne, Joe Gray

Agendia appointed last week six new members to its clinical and scientific advisory board. The advisors will review early research programs and provide academic and clinical evaluations. The advisory board will be chaired by Piet Borst, emeritus director of the Netherlands Cancer Institute. Members include Jose Baselga, professor of medicine at Vall d'Hebron University Hospital in Barcelona, Spain; Matt van de Rijn, professor of pathology a Stanford University; David Kerr, professor of clinical pharmacology at the University of Oxford in the UK; C. Kent Osborne, professor of medicine at Baylor College of Medicine; and Joe Gray, director of the life sciences division at the Lawrence Berkeley National Laboratory.